Sindy T. Kim
- Pulmonary and Respiratory Medicine top 0.05%
- Molecular Biology top 1%
- Oncology top 0.5%
- Cancer Research top 0.2%
- Surgery top 5%
- Co-authors
- Robert J. MotzerM. Dror MichaelsonRobert A. FiglinRonald M. BukowskiCharles M. BaumIsan ChenThomas E. HutsonSylvie Négrier
- Topics
- Renal cell carcinoma treatment (14 papers)Renal and related cancers (8 papers)Pancreatic and Hepatic Oncology Research (5 papers)
- Partner nations
- United StatesGermanyFrance
In The Last Decade
Sindy T. Kim
22 papers receiving 10.7k citations
Hit Papers
Peers
Comparison fields: 5 of 110
- Pulmonary and Respiratory Medicine 8.4k
- Molecular Biology 5.9k
- Oncology 4.6k
- Cancer Research 3.9k
- Surgery 774
Countries citing papers authored by Sindy T. Kim
This map shows the geographic impact of Sindy T. Kim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sindy T. Kim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sindy T. Kim more than expected).
Fields of papers citing papers by Sindy T. Kim
This network shows the impact of papers produced by Sindy T. Kim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sindy T. Kim. The network helps show where Sindy T. Kim may publish in the future.
Co-authorship network of co-authors of Sindy T. Kim
This figure shows the co-authorship network connecting the top 25 collaborators of Sindy T. Kim. A scholar is included among the top collaborators of Sindy T. Kim based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sindy T. Kim. Sindy T. Kim is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 11 | |
| 2 | 136 | |
| 3 | The cyclin-dependent kinase 4/6 inhibitor palbociclib in combination with letrozole versus letrozole alone as first-line treatment of oestrogen receptor-positive, HER2-negative, advanced breast cancer (PALOMA-1/TRIO-18): a randomised phase 2 studybreakdown → | 1412 |
| 4 | 37 | |
| 5 | 47 | |
| 6 | 55 | |
| 7 | 14 | |
| 8 | 12 | |
| 9 | 22 | |
| 10 | 11 | |
| 11 | Overall Survival and Updated Results for Sunitinib Compared With Interferon Alfa in Patients With Metastatic Renal Cell Carcinomabreakdown → | 1711 |
| 12 | 34 | |
| 13 | 321 | |
| 14 | 162 | |
| 15 | 7 | |
| 16 | 77 | |
| 17 | Sunitinib versus Interferon Alfa in Metastatic Renal-Cell Carcinomabreakdown → | 4471 |
| 18 | 30 | |
| 19 | Sunitinib in Patients With Metastatic Renal Cell Carcinomabreakdown → | 969 |
| 20 | Activity of SU11248, a Multitargeted Inhibitor of Vascular Endothelial Growth Factor Receptor and Platelet-Derived Growth Factor Receptor, in Patients With Metastatic Renal Cell Carcinomabreakdown → | 1304 |
About Sindy T. Kim
Sindy T. Kim is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Cancer Research, having authored 22 papers that have together received 10.9k indexed citations. Recurring topics across this work include Renal cell carcinoma treatment (14 papers), Renal and related cancers (8 papers) and Pancreatic and Hepatic Oncology Research (5 papers). The work is most often cited by research in Cancer Research (3.9k citations), Pulmonary and Respiratory Medicine (8.4k citations) and Oncology (4.6k citations). Sindy T. Kim has collaborated with scholars based in United States, Germany and France. Frequent co-authors include Robert J. Motzer, M. Dror Michaelson, Robert A. Figlin, Ronald M. Bukowski, Charles M. Baum, Isan Chen, Thomas E. Hutson, Sylvie Négrier, Cezary Szczylik and Piotr Tomczak. Their work appears in journals such as New England Journal of Medicine, JAMA and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.